LC-MS-based urinary metabolite signatures in idiopathic Parkinson's disease

Journal of Proteome Research

Volumn 14, Issue 1, 2015, Pages 467-478

  Luan, Hemi ^a   Liu, Liang Feng ^a   Meng, Nan ^b   Tang, Zhi ^a   Chua, Ka Kit ^a   Chen, Lei Lei ^a   Song, Ju Xian ^a   Mok, Vincent C T ^c   Xie, Li Xia ^d   Li, Min ^a   Cai, Zongwei ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b BGI SHENZHEN   (China)

^c and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^d GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

drosophila; idiopathic Parkinson's disease; metabolic phenotype; metabolite signatures; urinary metabolomics

Indexed keywords

ALPHA SYNUCLEIN; BIOLOGICAL MARKER; FATTY ACID; HISTIDINE; KYNURENINE; NUCLEOTIDE; PHENYLALANINE; STEROID; TRYPTOPHAN; TYROSINE;

ADULT; AGED; AMINO ACID METABOLISM; ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DROSOPHILA MELANOGASTER; FATTY ACID OXIDATION; FEMALE; FRUIT FLY MODEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTIDINE METABOLISM; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; METABOLIC REGULATION; METABOLOMICS; NONHUMAN; NUCLEOTIDE METABOLISM; PARKINSON DISEASE; PHENOTYPE; PHENYLALANINE METABOLISM; STEROIDOGENESIS; TRYPTOPHAN METABOLISM; TYROSINE METABOLISM; URINALYSIS; ANIMAL; BIOSYNTHESIS; LIQUID CHROMATOGRAPHY; METABOLISM; PROCEDURES; URINE;

DROSOPHILA MELANOGASTER;

ALPHA-SYNUCLEIN; ANIMALS; BIOMARKERS; CHROMATOGRAPHY, LIQUID; DROSOPHILA MELANOGASTER; FATTY ACIDS; HISTIDINE; HUMANS; KYNURENINE; MASS SPECTROMETRY; METABOLOMICS; NUCLEOTIDES; PARKINSON DISEASE; PHENOTYPE; PHENYLALANINE; STEROIDS; TRYPTOPHAN; TYROSINE;

EID: 84920268395     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr500807t     Document Type: Article

References (68)

1. de Lau, L. M.; Breteler, M. M. Epidemiology of Parkinson's disease Lancet Neurol. 2006, 5 (6) 525-535
2. Rocca, W. A. Prevalence of Parkinson's disease in China Lancet Neurol. 2005, 4 (6) 328-329
3. Dorsey, E.; Constantinescu, R.; Thompson, J.; Biglan, K.; Holloway, R.; Kieburtz, K.; Marshall, F.; Ravina, B.; Schifitto, G.; Siderowf, A. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030 Neurology 2007, 68 (5) 384-386
4. Jenner, P.; Morris, H. R.; Robbins, T. W.; Goedert, M.; Hardy, J.; Ben-Shlomo, Y.; Bolam, P.; Burn, D.; Hindle, J. V.; Brooks, D. Parkinson's disease - the debate on the clinical phenomenology, aetiology, pathology and pathogenesis J. Parkinson's Dis. 2013, 3 (1) 1-11
5. Sprenger, F.; Poewe, W. Management of motor and non-motor symptoms in Parkinson's disease CNS Drugs 2013, 27 (4) 259-272
6. Kaidanovich-Beilin, O.; Cha, D. S.; McIntyre, R. S. Crosstalk between metabolic and neuropsychiatric disorders F1000 Biol. Repl 2012, 4, 14
7. Henchcliffe, C.; Beal, M. F. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis Nat. Clin. Pract. Neurol. 2008, 4 (11) 600-609
8. Quinones, M. P.; Kaddurah-Daouk, R. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases Neurobiol. Dis. 2009, 35 (2) 165-176
9. Lei, S.; Powers, R. NMR Metabolomics Analysis of Parkinson's Disease Curr. Metabolomics 2013, 1 (3) 191-209
10. Chahine, L. M.; Stern, M. B.; Chen-Plotkin, A. Blood-based biomarkers for Parkinson's disease Parkinsonism Relat. Disord. 2014, 20 (Suppl 1) S99-S103
11. Lewitt, P. A.; Li, J.; Lu, M.; Beach, T. G.; Adler, C. H.; Guo, L. 3-hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis Mov. Disord. 2013, 28 (12) 1653-1660
12. Michell, A. W.; Mosedale, D.; Grainger, D. J.; Barker, R. A. Metabolomic analysis of urine and serum in Parkinson's disease Metabolomics 2008, 4 (3) 191-201
13. Bogdanov, M.; Matson, W. R.; Wang, L.; Matson, T.; Saunders-Pullman, R.; Bressman, S. S.; Flint Beal, M. Metabolomic profiling to develop blood biomarkers for Parkinson's disease Brain 2008, 131 (Pt 2) 389-396
14. Poliquin, P. O.; Chen, J.; Cloutier, M.; Trudeau, L.-é.; Jolicoeur, M. Metabolomics and In-Silico Analysis Reveal Critical Energy Deregulations in Animal Models of Parkinson's Disease PLoS One 2013, 8 (7) e69146
15. Musgrove, R.; Horne, J.; Wilson, R.; King, A.; Edwards, L.; Dickson, T. The metabolomics of alpha-synuclein (SNCA) gene deletion and mutation in mouse brain Metabolomics 2014, 10 (1) 114-122
16. Johansen, K. K.; Wang, L.; Aasly, J. O.; White, L. R.; Matson, W. R.; Henchcliffe, C.; Beal, M. F.; Bogdanov, M. Metabolomic profiling in LRRK2-related Parkinson's disease PLoS One 2009, 4 (10) e7551
17. Roede, J. R.; Uppal, K.; Park, Y.; Lee, K.; Tran, V.; Walker, D.; Strobel, F. H.; Rhodes, S. L.; Ritz, B.; Jones, D. P. Serum metabolomics of slow vs. rapid motor progression Parkinson's disease: a pilot study PLoS One 2013, 8 (10) e77629
18. Williams-Gray, C. H.; Foltynie, T.; Brayne, C. E.; Robbins, T. W.; Barker, R. A. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort Brain 2007, 130 (Pt 7) 1787-1798
19. Wang, X. J.; Zhang, A. H.; Han, Y.; Wang, P.; Sun, H.; Song, G. C.; Dong, T. W.; Yuan, Y.; Yuan, X. X.; Zhang, M.; Xie, N.; Zhang, H.; Dong, H.; Dong, W. Urine Metabolomics Analysis for Biomarker Discovery and Detection of Jaundice Syndrome in Patients With Liver Disease Mol. Cell. Proteomics 2012, 11 (8) 370-380
20. Cheng, Y.; Xie, G.; Chen, T.; Qiu, Y.; Zou, X.; Zheng, M.; Tan, B.; Feng, B.; Dong, T.; He, P.; Zhao, L.; Zhao, A.; Xu, L. X.; Zhang, Y.; Jia, W. Distinct urinary metabolic profile of human colorectal cancer J. Proteome Res. 2012, 11 (2) 1354-1363
21. Dunn, W. B.; Broadhurst, D.; Begley, P.; Zelena, E.; Francis-McIntyre, S.; Anderson, N.; Brown, M.; Knowles, J. D.; Halsall, A.; Haselden, J. N.; Nicholls, A. W.; Wilson, I. D.; Kell, D. B.; Goodacre, R. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry Nat. Protoc. 2011, 6 (7) 1060-1083
22. Luan, H.; Chen, X.; Zhong, S.; Yuan, X.; Meng, N.; Zhang, J.; Fu, J.; Xu, R.; Lee, C.; Song, S.; Jiang, H.; Xu, X. Serum metabolomics reveals lipid metabolism variation between coronary artery disease and congestive heart failure: a pilot study Biomarkers 2013, 18 (4) 314-321
23. Luan, H.; Meng, N.; Liu, P.; Feng, Q.; Lin, S.; Fu, J.; Davidson, R.; Chen, X.; Rao, W.; Chen, F.; Jiang, H.; Xu, X.; Cai, Z.; Wang, J. Pregnancy-Induced Metabolic Phenotype Variations in Maternal Plasma J. Proteome Res. 2014, 13 (3) 1527-1536
24. Kuhl, C.; Tautenhahn, R.; Bottcher, C.; Larson, T. R.; Neumann, S. CAMERA: an integrated strategy for compound spectra extraction and annotation of liquid chromatography/mass spectrometry data sets Anal. Chem. 2012, 84 (1) 283-289
25. Smith, C. A.; Want, E. J.; O'Maille, G.; Abagyan, R.; Siuzdak, G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification Anal. Chem. 2006, 78 (3) 779-787
26. Want, E. J.; Wilson, I. D.; Gika, H.; Theodoridis, G.; Plumb, R. S.; Shockcor, J.; Holmes, E.; Nicholson, J. K. Global metabolic profiling procedures for urine using UPLC-MS Nat. Protoc. 2010, 5 (6) 1005-1018
27. Houtkooper, R. H.; Argmann, C.; Houten, S. M.; Canto, C.; Jeninga, E. H.; Andreux, P. A.; Thomas, C.; Doenlen, R.; Schoonjans, K.; Auwerx, J. The metabolic footprint of aging in mice Sci. Rep. 2011, 1
28. Marti, M. J.; Tolosa, E. Parkinson disease: New guidelines for diagnosis of Parkinson disease Nat. Rev. Neurol. 2013, 9 (4) 190-191
29. Xia, J.; Mandal, R.; Sinelnikov, I. V.; Broadhurst, D.; Wishart, D. S. MetaboAnalyst 2.0 - a comprehensive server for metabolomic data analysis Nucleic Acids Res. 2012, 40 (Web Server issue) W127-W133
30. Campesan, S.; Green, E. W.; Breda, C.; Sathyasaikumar, K. V.; Muchowski, P. J.; Schwarcz, R.; Kyriacou, C. P.; Giorgini, F. The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease Curr. Biol. 2011, 21 (11) 961-966
31. Pandey, U. B.; Nichols, C. D. Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery Pharmacol. Rev. 2011, 63 (2) 411-436
32. Eller, M.; Williams, D. R. Biological fluid biomarkers in neurodegenerative parkinsonism Nat. Rev. Neurol. 2009, 5 (10) 561-570
33. Bolner, A.; Pilleri, M.; De Riva, V.; Nordera, G. P. Plasma and urinary HPLC-ED determination of the ratio of 8-OHdG/2-dG in Parkinson's disease Clin. Lab. 2011, 57 (11-12) 859-866
34. Charlett, A.; Dobbs, R. J.; Purkiss, A. G.; Wright, D. J.; Peterson, D. W.; Weller, C.; Dobbs, S. M. Cortisol is higher in parkinsonism and associated with gait deficit Acta Neurol. Scand. 1998, 97 (2) 77-85
35. Djamshidian, A.; O'Sullivan, S. S.; Papadopoulos, A.; Bassett, P.; Shaw, K.; Averbeck, B. B.; Lees, A. Salivary cortisol levels in Parkinson' disease and its correlation to risk behaviour J. Neurol., Neurosurg. Psychiatry 2011, 82 (10) 1107-1111
36. Hartmann, A.; Veldhuis, J. D.; Deuschle, M.; Standhardt, H.; Heuser, I. Twenty-four hour cortisol release profiles in patients with Alzheimer's and Parkinson's disease compared to normal controls: Ultradian secretory pulsatility and diurnal variation Neurobiol. Aging 1997, 18 (3) 285-289
37. Ros-Bernal, F.; Hunot, S.; Herrero, M. T.; Parnadeau, S.; Corvol, J. C.; Lu, L. X.; Alvarez-Fischer, D.; Carrillo-de Sauvage, M. A.; Saurini, F.; Coussieu, C.; Kinugawa, K.; Prigent, A.; Hoglinger, G.; Hamon, M.; Tronche, F.; Hirsch, E. C.; Vyas, S. Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism Proc. Natl. Acad. Sci. U.S.A. 2011, 108 (16) 6632-6637
38. Smith, L. K.; Jadavji, N. M.; Colwell, K. L.; Perehudoff, S. K.; Metz, G. A. Stress accelerates neural degeneration and exaggerates motor symptoms in a rat model of Parkinson's disease Eur. J. Neurosci. 2008, 27 (8) 2133-2146
39. Kibel, A.; Drenjancevic-Peric, I. Impact of glucocorticoids and chronic stress on progression of Parkinson's disease Med. Hypotheses 2008, 71 (6) 952-956
40. Bagieva, G. K.; Fedorova, T. N.; Stvolinsky, S. L.; Boldyrev, A. A.; Ivanova-Smolenskaya, I. A.; Illarioshkin, S. N. Oxidative stress in the pathogenesis of Parkinson's disease Mov. Disord. 2004, 19, S266-S266
41. Joergensen, A.; Broedbaek, K.; Weimann, A.; Semba, R. D.; Ferrucci, L.; Joergensen, M. B.; Poulsen, H. E., Association between Urinary Excretion of Cortisol and Markers of Oxidatively Damaged DNA and RNA in Humans. PLoS One 2011, 6, (6).
42. Abou-Sleiman, P. M.; Muqit, M. M. K.; Wood, N. W. Expanding insights of mitochondrial dysfunction in Parkinson's disease Nat. Rev. Neurosci. 2006, 7 (3) 207-219
43. Beal, M. F. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol. 1992, 31 (2) 119-130
44. Haorah, J.; Rump, T. J.; Xiong, H. G., Reduction of Brain Mitochondrial beta-Oxidation Impairs Complex I and V in Chronic Alcohol Intake: The Underlying Mechanism for Neurodegeneration. PLoS One 2013, 8, (8).
45. Vreken, P.; van Lint, A. E.; Bootsma, A. H.; Overmars, H.; Wanders, R. J.; van Gennip, A. H. Rapid diagnosis of organic acidemias and fatty-acid oxidation defects by quantitative electrospray tandem-MS acyl-carnitine analysis in plasma Adv. Exp. Med. Biol. 1999, 466, 327-337
46. Reuter, S. E.; Evans, A. M. Carnitine and Acylcarnitines Pharmacokinetic, Pharmacological and Clinical Aspects Clin. Pharmacokinet. 2012, 51 (9) 553-572
47. Tiligada, E.; Kyriakidis, K.; Chazot, P. L.; Passani, M. B. Histamine pharmacology and new CNS drug targets CNS Neurosci. Ther. 2011, 17 (6) 620-628
48. Prell, G. D.; Green, J. P. Histamine metabolites and pros-methylimidazoleacetic acid in human cerebrospinal fluid Agents Actions Suppl 1991, 33, 343-363
49. Rinne, J. O.; Anichtchik, O. V.; Eriksson, K. S.; Kaslin, J.; Tuomisto, L.; Kalimo, H.; Roytta, M.; Panula, P. Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy J. Neurochem. 2002, 81 (5) 954-960
50. Walterscheid, J. P.; Nghiem, D. X.; Kazimi, N.; Nutt, L. K.; McConkey, D. J.; Norval, M.; Ullrich, S. E. Cis-urocanic acid, a sunlight-induced immunosuppressive factor, activates immune suppression via the 5-HT2A receptor Proc. Natl. Acad. Sci. U.S.A. 2006, 103 (46) 17420-17425
51. Speciale, C.; Hares, K.; Schwarcz, R.; Brookes, N. High-affinity uptake of L-kynurenine by a Na+-independent transporter of neutral amino acids in astrocytes J. Neurosci. 1989, 9 (6) 2066-2072
52. Fukui, S.; Schwarcz, R.; Rapoport, S. I.; Takada, Y.; Smith, Q. R. Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism J. Neurochem. 1991, 56 (6) 2007-2017
53. Moroni, F. Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites Eur. J. Pharmacol. 1999, 375 (1-3) 87-100
54. Sas, K.; Robotka, H.; Toldi, J.; Vecsei, L. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders J. Neurol. Sci. 2007, 257 (1-2) 221-239
55. Schuck, P. F.; Tonin, A.; Ferreira, G. D.; Viegas, C. M.; Latini, A.; Wannmacher, C. M. D.; Wyse, A. T. D.; Dutra, C. S.; Wajner, M. Kynurenines impair energy metabolism in rat cerebral cortex Cell. Mol. Neurobiol. 2007, 27 (1) 147-160
56. Vecsei, L.; Szalardy, L.; Fulop, F.; Toldi, J. Kynurenines in the CNS: recent advances and new questions Nat. Rev. Drug Discovery 2013, 12 (1) 64-82
57. Tohgi, H.; Abe, T.; Takahashi, S.; Takahashi, J.; Hamato, H. Concentrations of serotonin and its related substances in the cerebrospinal fluid of parkinsonian patients and their relations to the severity of symptoms Neurosci. Lett. 1993, 150 (1) 71-74
58. Hartai, Z.; Klivenyi, P.; Janaky, T.; Penke, B.; Dux, L.; Vecsei, L. Kynurenine metabolism in plasma and in red blood cells in Parkinson's disease J. Neurol. Sci. 2005, 239 (1) 31-35
59. Mayeux, R.; Stern, Y.; Cote, L.; Williams, J. B. Altered serotonin metabolism in depressed patients with parkinson's disease Neurology 1984, 34 (5) 642-646
60. Karimova, M.; Aleuov, Sh. A. Changes in the blood level of serotonin in Parkinson disease Vopr. Med. Khim. 1988, 34 (1) 45-47
61. Mokhtarani, M.; Diaz, G. A.; Rhead, W.; Lichter-Konecki, U.; Bartley, J.; Feigenbaum, A.; Longo, N.; Berquist, W.; Berry, S. A.; Gallagher, R.; Bartholomew, D.; Harding, C. O.; Korson, M. S.; McCandless, S. E.; Smith, W.; Vockley, J.; Bart, P. S.; Kronn, D.; Zori, R.; Cederbaum, S.; Dorrani, N.; Merritt, J. L.; Sreenath-Nagamani, S.; Summar, M.; LeMons, C.; Dickinson, K.; Coakley, D. F.; Moors, T. L.; Lee, B.; Scharschmidt, B. F. Urinary phenylacetylglutamine as dosing biomarker for patients with urea cycle disorders Mol. Genet. Metab. 2012, 107 (3) 308-314
62. Mokhtarani, M.; Diaz, G. A.; Rhead, W.; Berry, S. A.; Lichter-Konecki, U.; Feigenbaum, A.; Schulze, A.; Longo, N.; Bartley, J.; Berquist, W.; Gallagher, R.; Smith, W.; McCandless, S. E.; Harding, C.; Rockey, D. C.; Vierling, J. M.; Mantry, P.; Ghabril, M.; Brown, R. S.; Dickinson, K.; Moors, T.; Norris, C.; Coakley, D.; Milikien, D. A.; Nagamani, S. C.; LeMons, C.; Lee, B.; Scharschmidt, B. F. Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio Mol. Genet. Metab. 2013, 110 (4) 446-453
63. Kobayashi, K.; Koide, Y.; Yoshino, K.; Shohmori, T. P-hydroxyphenylacetic acid concentrations in cerebrospinal fluid No to Shinkei 1982, 34 (8) 769-774
64. Sandler, M.; Karoum, F.; Ruthven, C. R.; Calne, D. B. m-Hydroxyphenylacetic acid formation from L-dopa in man: suppression by neomycin Science 1969, 166 (3911) 1417-1418
65. Uversky, V. N.; Li, J.; Fink, A. L. Trimethylamine-N-oxide-induced folding of alpha-synuclein FEBS Lett. 2001, 509 (1) 31-35
66. Heijtza, R. D.; Wang, S. G.; Anuar, F.; Qian, Y.; Bjorkholm, B.; Samuelsson, A.; Hibberd, M. L.; Forssberg, H.; Pettersson, S. Normal gut microbiota modulates brain development and behavior Proc. Natl. Acad. Sci. U.S.A. 2011, 108 (7) 3047-3052
67. Li, M.; Wang, B. H.; Zhang, M. H.; Rantalainen, M.; Wang, S. Y.; Zhou, H. K.; Zhang, Y.; Shen, J.; Pang, X. Y.; Zhang, M. L.; Wei, H.; Chen, Y.; Lu, H. F.; Zuo, J.; Su, M. M.; Qiu, Y. P.; Jia, W.; Xiao, C. N.; Smith, L. M.; Yang, S. L.; Holmes, E.; Tang, H. R.; Zhao, G. P.; Nicholson, J. K.; Li, L. J.; Zhao, L. P. Symbiotic gut microbes modulate human metabolic phenotypes Proc. Natl. Acad. Sci. U.S.A. 2008, 105 (6) 2117-2122
68. Marcobal, A.; Kashyap, P. C.; Nelson, T. A.; Aronov, P. A.; Donia, M. S.; Spormann, A.; Fischbach, M. A.; Sonnenburg, J. L. A metabolomic view of how the human gut microbiota impacts the host metabolome using humanized and gnotobiotic mice ISME J. 2013, 7 (10) 1933-1943